FDA-PR2026-10-08

Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter

Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓

Product photos

Label, Brevital Sodium Methohexital Sodium For Injection 500 mg/vial with Lot 86930

Label, Brevital Sodium Methohexital Sodium For Injection 500 mg/vial with Lot 88623

Hazard

FOR IMMEDIATE RELEASE - ROCHESTER, MI– October 8, 2026 –Par Health is voluntarily recalling two lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose.

Official notice

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/par-health-issues-voluntary-nationwide-recall-two-lots-brevitalr-sodium-500-mgvial-civ-methohexital

More Par Health recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.